Fund Holdings — Finepoint Capital LP

Total Portfolio Value:
$289.11M
Total Bought:
$71.05M
Total Sold:
$33.04M
Net Transaction:
+$38.01M
Notable People:
Herbert Schwind Wagner, Fpcap Llc, Steven Laurence Lefkowitz
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Cytokinetics, Incorporated(CYTK)431,693431,6930$12.72M$36.04M12.47%+$23.32M
Acadia Pharmaceuticals Inc556,553769,653+213,100$11.60M$24.10M8.34%+$12.50M
Amicus Therapeutics Inc
COM
1,489,0251,489,0250$18.11M$21.13M7.31%+$3.02M
Arvinas, Inc.(ARVN)504,700504,7000$9.91M$20.77M7.19%+$10.86M
Ascendis Pharma A/SADR(ASND)163,772163,7720$15.34M$20.63M7.13%+$5.29M
Springworks Therapeutics Inc556,928556,9280$12.88M$20.33M7.03%+$7.45M
Home Plate Acquisition CorpW EXP 09 30 202690,000331,416-358,584$0$20.01M6.92%+$20.01M
Lakefront Biotherapeutics NVADR(LKFT)458,659458,6590$15.85M$18.64M6.45%+$2.80M
Revolution Medicines, Inc.(RVMD)427,000617,100+190,100$11.82M$17.70M6.12%+$5.88M
Liberty Broadband CorpCOM SER C0184,460+184,460$0$14.87M5.14%+$14.87M
Relay Therapeutics, Inc.(RLAY)870,8701,317,870+447,000$7.32M$14.51M5.02%+$7.19M
Morphic Holding Inc325,356496,856+171,500$7.45M$14.35M4.96%+$6.90M
Sarepta Therapeutics, Inc.(SRPT)145,357145,3570$17.62M$14.02M4.85%-$3.60M
Travere Therapeutics, Inc.(TVTX)895,8211,435,321+539,500$8.01M$12.90M4.46%+$4.89M
Prothena Corp PlcSHS
SHS
349,300349,3000$16.85M$12.69M4.39%-$4.16M
Solid Biosciences Inc961,251961,2510$2.42M$5.90M2.04%+$3.48M
Calidi Biotherapeutics Inc125,000125,0000$415.6K$188.8K0.07%-$226.9K
Churchill Capital Corp ViiW EXP 02 29 202548,000548,0000$168.8K$71.3K0.02%-$97.5K
MoonLake ImmunotherapeuticsCL A(MLTX)331,416895,000+563,584$18.89M$62.7K0.02%-$18.83M
Concord Acquisition Corp IIW EXP 99 99 999(CNDA)408,333408,3330$42.6K$53.1K0.02%+$10.5K
Calidi Biotherapeutics IncW EXP 03 14 202655,200655,2000$144.1K$32.8K0.01%-$111.4K
Ross Acquisition Corp IiW EXP 02 01 202439,666439,6660$49.0K$24.6K0.01%-$24.4K
Compass Digital Acquisition CorpW EXP 09 29 202459,906459,9060$101.3K$22.3K0.01%-$79.0K
Marblegate Acquisition CorpW EXP 08 31 202735,000735,0000$13.5K$22.1K0.01%+$8.5K
Swiftmerge Acquisition CorpW EXP 12 13 202490,000490,0000$34.6K$20.1K0.01%-$14.5K
Ys Biopharma Co LtdW EXP 03 15 202489,999489,9990$17.1K$13.3K0.00%-$3.9K
ARES ACQUISITION CORP*W EXP 02/02/202504,7060-504,706$333.6K$0—-$333.6K
BRIDGETOWN HOLDINGS LTD*W EXP 09/30/202895,0000-895,000$304.3K$0—-$304.3K
CEREVEL THERAPEUTICS HLDNG ICOM563,3450-563,345$12.30M$0—-$12.30M
CHURCHILL CAPITAL CORP V*W EXP 10/29/202612,0000-612,000$0$0—$0
CHURCHILL CAPITAL CORP VI*W EXP 02/17/202540,0000-540,000$86.4K$0—-$86.4K
Page 1 of 1
Finepoint Capital LP — 13F Holdings — Q4 2023 | TickerTrail